ClinicalTrials.Veeva

Menu

PERsonalized Mammographic Screening in Norway (PERMS)

N

Norwegian Institute of Public Health

Status

Not yet enrolling

Conditions

Mammographic Breast Density
Breast Cancer
Risk Stratification

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

The aim of this study is to assess attendance among women invited to additional breast imaging because they were identified as having an increased risk of breast cancer at screening. High-risk women were defined in two studies: Study A; women with high mammographic density, representing approximately 3-5% of screened women, and Study B; women with a false-positive screening result. Women in Study A will be offered an additional screening examination with digital breast tomosynthesis immediately within 6 months after the screening examination. Women in Study B will be offered an additional standard digital mammography examination one year after their initial screening.

Enrollment

3,000 estimated patients

Sex

Female

Ages

50 to 71 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • invited to screening
  • extremely dense breast (Study A) or a false positive screening result (Study B)

Exclusion criteria

  • Opted out or not signed written consent related to the study
  • Women who have opted out from giving us permission to use screening data for quality assurance and research

Trial design

3,000 participants in 1 patient group

Women attending mammographic screening at three sites in BreastScreen Norway
Description:
Those 3-5% with the highest mammographic density in Study A and those with a false positive screening result in Study B will be offered additional imaging with digital breast tomosynthesis within 6 months after the screening examination (A) and an additional standard screening examination after one year (B)

Trial contacts and locations

0

Loading...

Central trial contact

Solveig Hofvind, PhD, professor

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems